Enhanced the immunity activity of HPV16 DNA vaccine by the combination CpG oligonucleotides adjuvant cloned into plasmid backbone and IL-28B gene adjuvant

Author:

zhou yan1,Zhang Ting1,Wang Zhirong1,Xu Xuemei1

Affiliation:

1. Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, Peking Union Medical College

Abstract

Abstract

Therapeutic human papillomavirus (HPV) DNA vaccine is an attractive option to control existed HPV infection and related lesions. The two early viral oncoproteins, E6 and E7, are continuously expressed in most HPV-related pre- and cancerous cells, and are ideal targets for therapeutic vaccines. We have previously developed HPV 16 DNA vaccines encoding mE7/HSP70, which generated significant antitumor effects in mice. In this study, we utilized multiple strategies including the insertion of CpG oligonucleotides (ODNs) into the backbone of vaccine vector, selection of cytokine gene adjuvants, combination of mE6/HSP70 and mE7/HSP70, vaccination with electroporation, to further enhance the potency of HPV16 DNA vaccine, We found that combination of built-in CpG adjuvant and IL-28B gene adjuvant could induce higher CD8+T cell response in mice. Moreover the plasmids mE6/HSP70 combined with mE7/HSP70 could synergistically enhance the specific CD8+T cell response. Furthermore, vaccination with CpG-modified mE7/HSP70 and mE6/HSP70, plus IL-28B gene adjuvant, generated significantly preventive and therapeutic antitumor effect against HPV E6- and E7-expressing tumors in C57BL/6 mice. Our results suggested that it may be promising to effectively control HPV infection and associated diseases by combining these multiple strategies in HPV DNA vaccine.

Publisher

Research Square Platform LLC

Reference56 articles.

1. The natural history of human papillomavirus infection;Sanjosé S;Best Pract Res Clin Obstet Gynaecol,2018

2. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases;Cheng MA;Hum Gene Ther,2018

3. The current status of immunotherapy for cervical cancer;Orbegoso C;Rep Pract Oncol Radiother

4. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research;Lee SJ;J Gynecol Oncol,2016

5. Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients;Kim TJ;Nat Commun,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3